Compounds > cholesteryl succinate
Page last updated: 2024-08-24

cholesteryl succinate and Malignant Melanoma

cholesteryl succinate has been researched along with Malignant Melanoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dresdale, AR; Sindelar, WF; Skornick, Y1
Bash, JA; Roberson, KM; Seigler, HF; Stuhlmiller, GM; Vervaert, CE; Wallack, MK1
Kolcová, V; Kovarík, J; Mechl, Z; Munzarová, M1
Bártek, J; Kovarík, J; Munzarová, M; Pacovský, Z; Rejthar, A; Zemanová, D1
Kovarik, J; Munzarová, M; Pacovsky, Z; Rejthar, A; Zemanová, D1

Other Studies

5 other study(ies) available for cholesteryl succinate and Malignant Melanoma

ArticleYear
Induction of delayed hypersensitivity reactions in cancer patients by cholesterol-hemisuccinate-treated autologous tumor cells.
    Journal of the National Cancer Institute, 1983, Volume: 70, Issue:3

    Topics: Carcinoma; Cell Separation; Cholesterol Esters; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunologic Techniques; Immunotherapy; Melanoma; Membrane Lipids; Neoplasms; Sarcoma; Skin Tests

1983
Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies.
    Journal of biological response modifiers, 1989, Volume: 8, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cholesterol Esters; Gangliosides; Humans; Immunization; Immunization Schedule; Melanoma; Mice; Radioimmunoassay; Reference Standards; Vaccinia virus; Viral Vaccines

1989
Skin tests with autologous cholesteryl hemisuccinate-treated tumor cells, DNCB and PPD and their relationship to prognosis in malignant melanoma patients.
    Neoplasma, 1988, Volume: 35, Issue:2

    Topics: Adult; Aged; Cholesterol Esters; Dinitrochlorobenzene; Female; Humans; Male; Melanoma; Middle Aged; Prognosis; Skin Tests

1988
Expression of HLA-DR antigens on tumour cells does not contribute to skin reactivity to autologous cholesteryl hemisuccinate (CHS)-treated tumour cells in patients with metastatic melanoma.
    Cancer immunology, immunotherapy : CII, 1987, Volume: 24, Issue:3

    Topics: Antigens, Neoplasm; Cholesterol Esters; HLA-D Antigens; HLA-DR Antigens; Humans; Immunity; Melanoma; Skin Tests

1987
Skin tests with autologous cholesteryl hemisuccinate treated tumour cells in cancer patients.
    Cancer immunology, immunotherapy : CII, 1985, Volume: 20, Issue:2

    Topics: Breast Neoplasms; Cholesterol Esters; Female; Humans; Hypersensitivity, Delayed; Melanoma; Neoplasms; Ovarian Neoplasms; Skin Tests

1985